Torres-Quesada 2022 BEC: Difference between revisions
Tindle Lisa (talk | contribs) No edit summary |
No edit summary Β |
||
(One intermediate revision by the same user not shown) | |||
Line 3: | Line 3: | ||
[[File:BEC-exlibris.png|right|290px|Bioenergetics Communications|link=https://www.bioenergetics-communications.org/index.php/bec/index]] | [[File:BEC-exlibris.png|right|290px|Bioenergetics Communications|link=https://www.bioenergetics-communications.org/index.php/bec/index]] | ||
{{Publication | {{Publication | ||
|title=Torres-Quesada O, Strich S, Stefan E (2022) Kinase perturbations redirect mitochondrial function in cancer. | |title=Torres-Quesada O, Strich S, Stefan E (2022) Kinase perturbations redirect mitochondrial function in cancer. Bioenerg Commun 2022.13. https://doi.org/10.26124/bec:2022-0013 | ||
|info=Bioenerg Commun 2022.13. [[File:OpenAccess-downloadPDF.png|200px||link=https://www.bioenergetics-communications.org/index.php/bec/article/view/torres-quesada_2022/115 |Open Access pdf]]<br /> ''published online'' 2022-11-15 [[File:WatchThePresentationYoutube_icon.jpg|200px|link=https://www.youtube.com/watch?v=2--Bt1T7Zu0&t=1819s|Β»''Watch the presentation''Β«]] | |info=Bioenerg Commun 2022.13. [[File:OpenAccess-downloadPDF.png|200px||link=https://www.bioenergetics-communications.org/index.php/bec/article/view/torres-quesada_2022/115 |Open Access pdf]]<br /> ''published online'' 2022-11-15 [[File:WatchThePresentationYoutube_icon.jpg|200px|link=https://www.youtube.com/watch?v=2--Bt1T7Zu0&t=1819s|Β»''Watch the presentation''Β«]] | ||
<br /><br /> | <br /><br /> | ||
|authors=Torres-Quesada Omar, Strich Sophie, Stefan Eduard | |authors=Torres-Quesada Omar, Strich Sophie, Stefan Eduard | ||
|year= | |year=2022 | ||
|journal=Bioenerg Commun | |journal=Bioenerg Commun |
Latest revision as of 16:31, 21 January 2024
Torres-Quesada O, Strich S, Stefan E (2022) Kinase perturbations redirect mitochondrial function in cancer. Bioenerg Commun 2022.13. https://doi.org/10.26124/bec:2022-0013 |
Β» Bioenerg Commun 2022.13.
published online 2022-11-15
Torres-Quesada Omar, Strich Sophie, Stefan Eduard (2022) Bioenerg Commun
Abstract: https://doi.org/10.26124/bec:2022-0013
Protein kinases take the center stage in numerous signaling pathways by phosphorylating compartmentalized protein substrates for controlling cell proliferation, cell cycle and metabolism. Kinase dysfunctions have been linked to numerous human diseases such as cancer. This has led to the development of kinase inhibitors which aim to target oncogenic kinase activities. The specificity of the cancer blockers depends on the range of targeted kinases. Therefore, the question arises of how cell-type-specific off-target effects impair the specificities of cancer drugs. Blockade of kinase activities has been shown to converge on the energetic organelle, the mitochondria. In this review, we highlight examples of selected major kinases that impact mitochondrial signaling. Further, we discuss pharmacological strategies to target kinase activities linked to cancer progression and redirecting mitochondrial function. Finally, we propose that cell-based recordings of mitochondrial bioenergetic states might predict off-target or identify specific on-target effects of kinase inhibitors. β’ Keywords: Kinases, signaling, mitochondria, kinase inhibitors, cancer, drug off-target effects β’ Bioblast editor: Tindle-Solomon L β’ O2k-Network Lab: AT Innsbruck Oroboros
ORCID: Torres-Quesada Omar, Stefan Eduard
Preprint
Labels: MiParea: Pharmacology;toxicology Pathology: Cancer
Organism: Human
MitoKIN, BEC